HCR — Health Issues
Education on FDA regulation of Human Cellular Tissue Products (HCTPs).
Lobbyists:
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
1st Quarter - Report · 2026
- Filing UUID
459b2c64-7888-49d3-a8cd-b5fd062db6e0- Type
Q1— 1st Quarter - Report- Period
- first_quarter
- Year
- 2026
- Posted
- 2026-04-20 21:23:40
- Income (reported)
- $50,000
- Expenses (reported)
- —
- Filing document
- Open on lda.senate.gov
Registrant (lobbying firm)
Consulting
- Contact
- NATE GASPAR
- Phone
- +1 434-989-7548
- Address
- zip:20001, city:Washington, state:DC, street:610 10th St. NW Suite 300
Issues lobbied + lobbyists (2)
MMM — Medicare/Medicaid
Issues related to coverage of and reimbursement for Human Cell & Tissue products. Issues related to coverage, including VIA Disc local coverage determination. LCD ID: L39962 - Coverage Indications, Limitations and/or Medical Necessity section to include non-coverage for all intervertebral disc injections for management of chronic low back pain. Issues related to skin substitute payment in 2026 Medicare Physician Fee Schedule Final Rule (CMS-1832-F) Skin Substitute Access and Payment Reform Act of 2025 (H.R. 5768/S. 2561). H.R.6852 - To amend title XVIII of the Social Security Act to adjust payment for skin substitute products under the Medicare program.
Lobbyists:
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE